Search For "bharat biotech"
Updated : 6 months ago IST
New Delhi [India], December 24 (ANI): The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday invited volunteers for the Phase III clinical trial of the indigenously developed COVID-19 vaccine candidate 'Covaxin' for which it is one of the sites.
Hyderabad (Telangana) [India], December 22 (ANI): Hyderabad-based Bharat Biotech and US-based biopharmaceutical firm Ocugen Inc on Tuesday announced that they have signed a binding letter of intent (LOI) to co-develop the Indian firm's COVID-19 vaccine candidate--Covaxin-- for the United Sta
Updated : 6 months, 1 week ago IST
New Delhi [India], December 16 (ANI): No serious adverse effect related to the vaccine has been reported by COVID-19 vaccine (BBV152) COVAXIN, the interim finding from the phase 1 clinical trial of COVAXIN has stated which has now been published in the pre-print version on Monday.
New Delhi [India], December 16 (ANI): With the start of COVID vaccination an immediate future in India, the phase III clinical trial for indigenously-developed Bharat Biotech's vaccine candidate COVAXIN is witnessing a shortage of volunteer participation, with a high refusal rate 70 per c
Rohtak (Haryana) [India], December 15 (ANI): Haryana Health Minister Anil Vij, who had tested positive for coronavirus after taking a trial dose of Bharat Biotech's COVID-19 vaccine 'Covaxin' has been referred to Medanta Hospital Gurugram on Tuesday.
Rohtak (Haryana) [India], December 14 (ANI): Haryana Home Minister Anil Vij, who had tested positive for coronavirus on December 5, was shifted to the Post-Graduate Institute of Medical Sciences (PGIMS) in Rohtak from Ambala's civil hospital.
Updated : 6 months, 2 weeks ago IST
Hyderabad (Telangana) [India], December 9 (ANI): Covaxin, a vaccine for COVID-19, will be available in the first quarter of next year, said Suchitra Ella, joint managing director of Bharat Biotech on Wednesday.
New Delhi [India], December 9 (ANI): The Ministry of External Affairs on Wednesday organised a tour of heads of missions and their representatives to the research and manufacturing facilities of the leading biotechnology companies, Bharat Biotech and Biological E, in Hyderabad.
New Delhi[India], December 9 (ANI): In a major development related to COVID-19 vaccine, Subject Expert Committee (SEC) of Drugs Controller General of India (DCGI) has asked for more safety and efficacy data from Serum Institute of India (SII) and Bharat Biotech for their COVID-19 vaccines
New Delhi [India], December 9 (ANI): The Ministry of Health and Family Welfare on Wednesday dismissed the media report about the rejection of Serum Institute India (SII) and Bharat Biotech's emergency use authorisation of COVID vaccine and called it "fake".
Hyderabad (Telangana) [India], December 9 (ANI): Many of the 60 foreign heads of missions who visited the biotech companies in Hyderabad-- Bharat Biotech and Biological E-- lauded the work being done at the Indian facilities for the development of Covid-19 vaccines.
New Delhi [India], December 9 (ANI): More than 60 foreign heads of missions will on Wednesday visit leading biotech companies in Hyderabad - Bharat Biotech and Biological E - which are developing vaccines against the novel coronavirus, sources said.